Shareholding for the Period Ended September 30, 2016
Thyrocare Technologies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here18-10-2016
18-10-2016
Board Meeting Intimation for Results & Closure of Trading Window
Thyrocare Technologies Ltd has informed BSE that a meeting of our Board of Directors of the Company will be held on October 24, 2016, inter alia, to consider and approve unaudited Stand-alone and Consolidated financial results of the Company for the quarter/ half year ended September 30, 2016.Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading window of the Company will remain closed...15-10-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Thyrocare Technologies Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.14-10-2016
Generation Next to step in at Thyrocare
Velumani is inducting both his children into business with bigger share in the hands of daughter11-10-2016
Intimation of Investors Meeting
Thyrocare Technologies Ltd has informed BSE regarding "Intimation of Investors Meeting".28-09-2016
Updates
Thyrocare Technologies Ltd has informed BSE that Mr. Hafeez Patel and Mr. Vinit Bolinjkar, Research Analysts of Ventura Capital would be meeting the Company's General Manager-Finance, Mr. Sachin Salvi, on September 28, 2016 at 11:00 a.m.No un-published Price-Sensitive Information will be shared during the meeting.27-09-2016
Intimation of Schedule of Analyst / Institutional Investor Meetings
Thyrocare Technologies Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".26-09-2016
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Thyrocare Technologies Ltd has informed BSE regarding the details of Voting results at the 16th Annual General Meeting (AGM) of the Company held on September 12, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report.14-09-2016
Outcome of AGM
Thyrocare Technologies Ltd has informed BSE that the 16th Annual General Meeting (AGM) of the Company was held on September 12, 2016.14-09-2016
Intimation of Schedule of Analyst / Institutional Investor Meetings
Thyrocare Technologies Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".04-09-2016